WO2008120741A1 - 塩基性線維芽細胞増殖因子の徐放性製剤 - Google Patents
塩基性線維芽細胞増殖因子の徐放性製剤 Download PDFInfo
- Publication number
- WO2008120741A1 WO2008120741A1 PCT/JP2008/056162 JP2008056162W WO2008120741A1 WO 2008120741 A1 WO2008120741 A1 WO 2008120741A1 JP 2008056162 W JP2008056162 W JP 2008056162W WO 2008120741 A1 WO2008120741 A1 WO 2008120741A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sustained release
- release preparation
- growth factor
- fibroblast growth
- basic fibroblast
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
本発明は、塩基性線維芽細胞増殖因子及び/又はその同族体を担持させたアガロースハイドロゲルを含有してなる徐放性製剤を提供する。好ましい徐放性製剤は、アガロースハイドロゲルがアガロースのみから調製されるもの、又は粒子状である。本発明はまた、前記徐放性製剤を製造するための、塩基性線維芽細胞増殖因子及び/又はその同族体とアガロースハイドロゲルの使用、並びに前記徐放性製剤及び当該徐放性製剤を血管新生促進又は組織再生に使用することができること又は使用すべきであることを記載した当該徐放性製剤に関する記載物を含む商業パッケージを提供する。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009507531A JPWO2008120741A1 (ja) | 2007-03-30 | 2008-03-28 | 塩基性線維芽細胞増殖因子の徐放性製剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007094703 | 2007-03-30 | ||
JP2007-094703 | 2007-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008120741A1 true WO2008120741A1 (ja) | 2008-10-09 |
Family
ID=39808321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/056162 WO2008120741A1 (ja) | 2007-03-30 | 2008-03-28 | 塩基性線維芽細胞増殖因子の徐放性製剤 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2008120741A1 (ja) |
WO (1) | WO2008120741A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012050184A1 (ja) * | 2010-10-15 | 2012-04-19 | 国立大学法人京都大学 | 徐放性医薬組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000178180A (ja) * | 1998-12-14 | 2000-06-27 | Univ Kyoto | 生体内に毛細血管が豊富な組織を作成するのに用いる新生血管床形成用用具 |
-
2008
- 2008-03-28 JP JP2009507531A patent/JPWO2008120741A1/ja active Pending
- 2008-03-28 WO PCT/JP2008/056162 patent/WO2008120741A1/ja active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000178180A (ja) * | 1998-12-14 | 2000-06-27 | Univ Kyoto | 生体内に毛細血管が豊富な組織を作成するのに用いる新生血管床形成用用具 |
Non-Patent Citations (3)
Title |
---|
HAGLUND B.O. ET AL.: "Dissolution Controlled Drug Release from Agarose Beads", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, vol. 20, no. 6, 1994, pages 947 - 959 * |
KURANE A. ET AL.: "In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor", BIOMATERIALS, vol. 28, 25 February 2007 (2007-02-25), pages 2830 - 2838, XP022004004 * |
LIU J. ET AL.: "SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel", EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 25, no. 2-3, 2005, pages 237 - 244, XP004903821 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012050184A1 (ja) * | 2010-10-15 | 2012-04-19 | 国立大学法人京都大学 | 徐放性医薬組成物 |
JP5860406B2 (ja) * | 2010-10-15 | 2016-02-16 | 国立大学法人京都大学 | 徐放性医薬組成物 |
US9301917B2 (en) | 2010-10-15 | 2016-04-05 | Kyoto University | Sustained-release pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
JPWO2008120741A1 (ja) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20130387T1 (hr) | Pripravak koji sadrži kitosan-glukan za zacjeljivanje rana i sprjeäśavanje lijepljenja zavoja na ranu | |
EP2298696A4 (en) | THREE-DIMENSIONAL MATRIXES OF STRUCTURED POROUS MONETITIS FOR TISSUE ENGINEERING AND BONE REGENERATION AND METHOD OF PREPARING THESE MATRICES | |
ZA200906800B (en) | Method for producing a catalyst consisting of a carrier body and a catalytically active mass applied to the surface of the carrier body | |
WO2009105761A3 (en) | Multi-functional wound dressing matrices and related methods | |
WO2010003104A3 (en) | Compositions and methods for tissue filling and regeneration | |
MX350761B (es) | Inhibidores de isoindolinona de fosfatidilinositol 3-cinasa. | |
EP2183358A4 (en) | PROCESS FOR THE PREPARATION OF DERMAL PAPER TISSUE EMPLOYING MESENCHYMAL STEM CELLS | |
IL216140B (en) | Use of compounds that bind covalently to cysteine 797 in the epidermal growth factor receptor in the preparation of drugs and the compounds for use as a drug to treat cancer | |
WO2009108934A3 (en) | Injectable calcium phosphate cememts formulated with bioactive agents and methods for making same | |
EP2301560A4 (en) | PHARMACEUTICAL AGENT FOR PROMOTING THE FUNCTIONAL REGENERATION OF DEGRADED TISSUE | |
WO2007093258A3 (en) | Porous magnesia and process for preparing the same | |
WO2013043385A3 (en) | Catalyst for producing acrylic acids and acrylates comprising vanadium and titanium | |
WO2010007441A3 (en) | Phosphopeptides and use of the same | |
WO2009087148A3 (en) | Analgesic apatitic calcium-phosphate cement | |
WO2012068356A3 (en) | Compositions and methods for improving the appearance of facial pores | |
WO2008120720A1 (ja) | 象牙質形成促進剤および象牙質形成覆髄材 | |
WO2008120741A1 (ja) | 塩基性線維芽細胞増殖因子の徐放性製剤 | |
WO2011136513A3 (ko) | 디히드록시벤조산 유도체를 포함하는 골이식용 또는 골충진용 조성물 | |
WO2010141824A3 (en) | Use of targeted nitroxide agents in bone healing | |
WO2012033323A3 (ko) | 산소 생성 화장료 조성물 | |
WO2011089531A3 (en) | Effects of the association of vitamin k2 and vitamin d3 in the consolidation of a bone fracture | |
WO2011041634A8 (en) | Pyrazole inhibitors of phosphatidylinositol 3-kinase | |
WO2012047007A3 (ko) | 손톱 또는 발톱 성장 촉진용 조성물 | |
ZA201109532B (en) | Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders | |
WO2010130409A3 (de) | Granulat zur neubildung von knochenmaterial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08739280 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009507531 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08739280 Country of ref document: EP Kind code of ref document: A1 |